Andrés Graziosi was appointed Head Pharma of the Latin America and Canada Region in May 2016, reporting to Paul Hudson, CEO Novartis Pharmaceuticals.
His previous position was as Country Pharma Organization Head in Russia, since July 2014, reporting to the Head of Pharma Region Europe. Before that role, he has served as CPO Head Argentina & Uruguay.
Leading the Argentinian CPO since 2011, Andrés and his team achieved outstanding successes in main areas of the business, ensuring significant top and bottom line growth of key products (Gilenya, Lucentis, Galvus, Tobi Podhaler) and contributed to develop key capabilities especially in Medical Marketing and KAM/Access functions.
Andrés joined Novartis in 2003 as Head, Financial Reporting and Analysis (FRA) Argentina, and subsequently has held a number of management positions including work in Novartis Head Quarters Basel with the Global Marketing Team in charge of developing and implementing new marketing and sales strategies for Lucentis. Later he served as Commercial and Access Head, Latin America.
Before joining Novartis, for more than 10 years Andres worked as a senior manager in PriceWaterhose Coopers (PwC) Transaction Services.
He is a CPA, and holds an MBA from ESEADE in Buenos Aires.